Advertising

Research
Volume 55, Issue 4, April 2026

Medication abortion in South Australia: A missed opportunity in general practice

Tahlee B Stevenson    Brigid Coombe    Janet Kelly   
doi: 10.31128/AJGP-05-25-7669   |    Download article
Cite this article    BIBTEX    REFER    RIS

Background and objectives
Nationally, legislative changes and regulatory reform support increased access to medication abortion within community and primary care settings. General practitioners (GPs) are well placed to provide this care, but the extent to which this is occurring remains unclear; here we seek to explore the experiences of consumers who accessed abortion care in South Australia between June 2023 and March 2024.
Methods
Anonymous survey.
Results
GPs are a common source of information for consumers seeking abortion care, with up to 40% of respondents indicating that they consulted with a GP prior to attending a specialist abortion clinic. Many had also attempted to access early medication abortion in general practice but were unable to, due to a lack of local, timely or affordable options.
Discussion
These findings suggest that the community expects to be able to access medication abortion within general practice settings, and that there is increasing and unmet demand for this service.
 
 

Medication abortion has revolutionised access to abortion care and the safety, efficacy, and acceptability of this method are irrefutable.1,2 Available for use in Australia up until 9 weeks of gestation, medication abortion provides consumers with the choice to forgo an invasive and expensive surgical procedure and instead facilitate an abortion in their own space, at a time that suits their schedule. Despite international availability, politicalisation and over regulation limited the use of medication abortion in Australia up until 2012.3 In the years following, accessibility remained inconsistent, as doctors were required to adhere to strict regulations that mandated additional training, required prescribers to be registered, and seek authorisation each time a prescription was made.3 These requirements were removed in July of 2023 in response to decriminalisation, regulatory reform and the push for increased accessibility.4 Within South Australia specifically, decriminalisation removed the legal requirement that abortion care could only be provided in hospitals, with two doctors present: thereby opening the possibility for provision in community settings. Despite general practitioners (GPs) being widely recognised as effective providers of comprehensive reproductive health care, currently there is limited provision of medication abortion in this setting.5 This paper will report on consumer experiences of attempting to access abortion care with GPs in South Australia.

Methods

Between June 2023 and March 2024, an anonymous survey was offered to all consumers over the age of 18 attending the Pregnancy Advisory Centre; a government funded, public healthcare service, which provided over 65% of all abortion care for South Australia in 2023.6 Within the 10‑month data collection period, the centre provided abortion care to a total of 2659 consumers. This survey aimed to explore access journeys, and identify barriers or challenges faced by consumers when attempting to access abortion care (Appendix 1, available online only). Participation was voluntary and paper-based surveys were provided with appointment registration paperwork. Response data was extracted and stored electronically; and analysed using descriptive statistics. This activity was funded via a Central Adelaide Local Health Network Executive Director of Nursing Grant, approved as a quality improvement project (QIP ID 5319) and received publication endorsement from the Central Adelaide Local Health Network (Reference Number: 20574).

Results

A total of 783 surveys were returned within the data collection period. Some respondents did not provide an answer for all questions, but any and all responses were included in analysis. All quotes contained within this section were provided by survey participants.

Participants were asked about how they found out about the service and whether they had attempted to access abortion care elsewhere. 780 respondents answered the question ‘How did you find out about the Pregnancy Advisory Centre’, with 40% (n = 308) indicating that information about the service had been provided to them by a GP. In response to the question ‘Did you try to access termination care from another provider prior to accessing the Pregnancy Advisory Centre’, 304 responses were received; with 34% (n = 104) of respondents indicating that they had first attempted to access abortion care with a GP prior to attending the Pregnancy Advisory Centre.

When asked what prevented or prohibited them from accessing care with the GP, numerous barriers were reported in free-text qualitative responses. These included struggling to find a practice or GP that provided access to medication abortion, especially when living in a rural or remote location.

There was no medication abortion service available at any of the GP practices I tried.

I live in a remote town and none of the GPs nearby do medication abortions.

Others highlighted that in instances where they could find a GP provider, that they either could not access a timely appointment with them;

The GP didn’t have appointments available quickly enough.

The only GP that provides the service was booked out.

Or that the logistical requirements, including the need for multiple appointments and the associated costs, were prohibitive.

Not many GPs offer the service and those that do require you to have three appointments and a scan elsewhere.

The cost of paying for the medicine, and all the appointments and a scan was too much with a GP.

A number of responses also suggested that there was a lack of awareness and knowledge about decriminalisation and the associated new laws and regulations. This resulted in some of the GPs being unsure or unaware that they could provide medication abortion services.

My GP didn’t even know the law had passed that allowed them to give out the medication.

My GP just told me that GPs can’t provide medication abortions.

Other GPs had told consumers that they lacked the experience or training required to provide abortion care.

The GP I visited told me they lacked experience and were unsure if they could provide termination options.

My GP told me they weren’t trained in this area.

Finally, some respondents reported that when attempting to locate a GP that would provide abortion care, they encountered providers that seemingly objected to its provision or attempted to sway their decision.

The GP told me they were a ‘family doctor’ and they didn’t do that kind of thing.

I had GPs cancel appointments on me when I told them I was booking to see them to talk about abortion.

The GP said they didn’t provide the service for ‘ethical reasons’ and they tried to convince me out of my decision.

Discussion

These results and quotes indicate that GPs are a common source of information for consumers seeking abortion care, particularly for early medication abortion; but a less reliable source of care provision. In this instance, all surveyed consumers were required to seek medication abortion care elsewhere because of inaccessibility, uncertainty or unwillingness of GPs to provide the service. This suggests that despite changes in legislation and streamlining of regulations, provision of medication abortion in general practice settings in South Australia is not currently enough to meet consumer demand and that there is a need for education and supportive structures to increase service provision.

Many barriers to medication abortion provision within the community setting have been defined within the literature, including inconsistent service provision which is fuelled by a lack of adequately skilled providers and the absence of workforce training opportunities.7 The insufficient coverage of content pertaining to abortion care within medical education likely contributes to a lack of understanding, awareness and preparedness to provide this care in medical graduates.8 Participants recounted experiences of GPs being unsure or unaware if they could legally provide medication abortion, highlighting the need for education that includes clear explanations of abortion laws, options and implications for consumers who are unable to access timely care. It must also be highlighted that in instances where individuals conscientiously object to providing abortion care, that they are legally required to disclose this to consumers, and without delay refer them on to another service or provider who will facilitate access.9 Failure to do so directly contravenes the law; although a recent study from Victoria demonstrates this is not uncommon and suggests that the absence of monitoring and reporting mechanisms and response strategies may contribute to non-compliance.10 While all participants in this instance eventually received care at the Pregnancy Advisory Centre, it is not clear whether this was the result of referral or whether those that experienced GP objection independently sourced another care provider.

The cost of medication abortion in community settings is another barrier and concern shared by consumers and providers alike. Survey participants recounted that accessing medication abortion with a GP required multiple appointments, including an ultrasound, and that the out-of-pocket costs and excessive time required for multiple visits made this option unappealing or unviable. Limitations with current funding models and inadequate Medicare rebates for the provision of abortion care likely contribute to this and may prevent or discourage GPs from becoming abortion providers.11 In Canberra, local government funding has been provided to overcome these limitations, ensure appropriate remuneration for providers, and no or minimal out of pocket costs for consumers.12 Additionally, research continues to highlight strategies that have helped to streamline access and reduce the need for these repeat appointments; such as the routine use of a urine test for follow up, telehealth provision, the removal of the need for an ultrasound when gestation can be reliably determined by clinical means (last menstrual period dates), and when there are no signs or symptoms that could indicate an ectopic pregnancy.13–15 These approaches are highlighted as best practice within the World Health Organization Abortion Care Guidelines16 and re-affirmed as safe and effective within the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Clinical Guideline for Abortion Care and other emerging international evidence;17–19 but these are yet to become common practice in Australia.

Although the perspectives of consumers who were able to successfully access abortion care with a GP were not captured in this instance, these findings provide timely insight into accessibility in the post-decriminalisation period. This insight suggests that there is demand for increased provision of medication abortion services within community settings and might be used to inform service planning. Another limitation is the relatively small sample surveyed. However, these findings build on the limited existing evidence that explores the accessibility of abortion care from the consumer perspective within South Australia.

Conclusion

Consumers seeking abortion care face unnecessary barriers in this time-sensitive area of healthcare, and there is increasing demand for early medication abortion to be provided within the general practice setting. As we strive to improve access nationally, we must support GPs to provide abortion care, while also ensuring that they are equipped with the knowledge pertaining to what is legal and should be available, and the ethical and legal implications of preventing or delaying access to this care. Sustainable investment in improving education, increasing training opportunities and better remuneration to support timely, streamlined and cost-effective models of abortion care provision will be critical to ensuring increased and equitable access for all Australians.

Competing interests: TBS is a member of the Australian Women’s Health Alliance Board. Authors had full access to all relevant data in this study, and supporting sources had no involvement in data analysis and interpretation, or in the writing of the article.
AI declaration: The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript.
Provenance and peer review: Not commissioned, externally peer reviewed.
Funding: Funding to undertake this research was obtained through SA Health, via a Central Adelaide Local Health Network Executive Director of Nursing Grant, awarded to TBS.
Correspondence to:
tahlee.stevenson@sa.gov.au
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Goldstone P, Walker C, Hawtin K. Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting. Aust N Z J Obstet Gynaecol 2017;57(3):366–71. doi: 10.1111/ajo.12608. Search PubMed
  2. Chen MJ, Creinin MD. Mifepristone with buccal misoprostol for medical abortion: A systematic review. Obstet Gynecol 2015;126(1):12–21. doi: 10.1097/AOG.0000000000000897. Search PubMed
  3. Baird B. Medical abortion in Australia: A short history. Reprod Health Matters 2015;23(46):169– 76. doi: 10.1016/j.rhm.2015.10.002. Search PubMed
  4. Healy E. Bodily autonomy: Australian women still face obstacles when seeking abortion services. Lens – Medicine and Health, 2024. Available at https://lens.monash.edu/@medicine-health/2024/05/06/1386674/bodily-autonomy-australian-women-still-face-obstacles-when-seeking-abortion-services [Accessed 17 February 2025]. Search PubMed
  5. Subasinghe AK, McGeechan K, Moulton JE, Grzeskowiak LE, Mazza D. Early medical abortion services provided in Australian primary care. Med J Aust 2021;215(8):366–70. doi: 10.5694/mja2.51275. Search PubMed
  6. South Australian Abortion Reporting Committee. Annual Report for the Year 2023. Preventive Health SA, 2024. Search PubMed
  7. Mazza D. Reimagining medical abortion in Australia: What do we need to do to meet women’s needs and ensure ongoing access? Med J Aust 2023;218(11):496–98. doi: 10.5694/mja2.51979. Search PubMed
  8. Cheng HC, de Costa C. Abortion education in Australian medical schools. Aust N Z J Obstet Gynaecol 2021;61(5):793–97. doi: 10.1111/ajo.13368. Search PubMed
  9. South Australian Termination of Pregnancy Act. SA, 2021. Available at www.legislation.sa.gov.au/__legislation/lz/c/a/termination%20of%20pregnancy%20act%202021/current/2021.7.auth.pdf [Accessed 1 May 2025]. Search PubMed
  10. Keogh LA, Gillam L, Bismark M, et al. Conscientious objection to abortion, the law and its implementation in Victoria, Australia: Perspectives of abortion service providers. BMC Med Ethics 2019;20(1):11. doi: 10.1186/s12910-019-0346-1. Search PubMed
  11. Deb S, Subasinghe AK, Mazza D. Providing medical abortion in general practice: General practitioner insights and tips for future providers. Aust J Gen Pract 2020;49(6):331–37. doi: 10.31128/AJGP-01-20-5198. Search PubMed
  12. Wisbey M. ACT GPs expand free abortion. Available at www1.racgp.org.au/newsgp/clinical/act-gps-expand-free-abortion-access [Accessed 17 February 2025]. Search PubMed
  13. Melville C, Goldstone P, Moosa N. Telephone follow-up after early medical abortion using Australia’s first low sensitivity urine pregnancy test. Aust N Z J Obstet Gynaecol 2023;63(6):797–802. doi: 10.1111/ajo.13731. Search PubMed
  14. Aiken A, Lohr PA, Lord J, Ghosh N, Starling J. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: A national cohort study. BJOG 2021;128(9):1464–74. doi: 10.1111/1471-0528.16668. Search PubMed
  15. Upadhyay UD, Raymond EG, Koenig LR, et al. Outcomes and safety of history based screening for medication abortion: A retrospective multicenter cohort study. JAMA Intern Med 2022;182(5):482–91. doi: 10.1001/jamainternmed.2022.0217. Search PubMed
  16. World Health Organization. Abortion care guideline. World Health Organization, 2022. Search PubMed
  17. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Clinical Guideline for Abortion Care: An evidence based guideline on abortion care in Australia and Aotearoa New Zealand. RANZCOG, 2023. Search PubMed
  18. Ralph LJ, Baba CF, Biggs MA, McNicholas C, Hagstrom Miller A, Grossman D. Comparison of no-test telehealth and in-person medication abortion. JAMA 2024;332(11):898–905. doi: 10.1001/jama.2024.10680. Search PubMed
  19. Upadhyay UD, Koenig LR, Meckstroth K, Ko J, Valladares ES, Biggs MA. Effectiveness and safety of telehealth medication abortion in the USA. Nat Med 2024;30(4):1191–98. doi: 10.1038/s41591-024-02834-w. Search PubMed

Access to healthcareMedical abortionWomen's health

Download article